Robeco Institutional Asset Management B.V. Trims Position in Stryker Co. (NYSE:SYK)

Robeco Institutional Asset Management B.V. cut its holdings in Stryker Co. (NYSE:SYK - Free Report) by 2.2% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 153,094 shares of the medical technology company's stock after selling 3,453 shares during the period. Robeco Institutional Asset Management B.V.'s holdings in Stryker were worth $55,121,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently added to or reduced their stakes in SYK. State Street Corp grew its position in Stryker by 2.2% during the third quarter. State Street Corp now owns 14,582,959 shares of the medical technology company's stock valued at $5,279,788,000 after purchasing an additional 316,404 shares in the last quarter. FMR LLC boosted its position in shares of Stryker by 3.0% in the third quarter. FMR LLC now owns 7,306,994 shares of the medical technology company's stock valued at $2,639,725,000 after acquiring an additional 215,782 shares during the period. Geode Capital Management LLC increased its holdings in shares of Stryker by 2.5% during the 3rd quarter. Geode Capital Management LLC now owns 6,905,126 shares of the medical technology company's stock worth $2,484,893,000 after purchasing an additional 165,490 shares during the period. Parnassus Investments LLC bought a new stake in shares of Stryker in the 3rd quarter worth approximately $762,798,000. Finally, Janus Henderson Group PLC lifted its holdings in shares of Stryker by 1.5% during the 3rd quarter. Janus Henderson Group PLC now owns 1,969,757 shares of the medical technology company's stock worth $711,594,000 after acquiring an additional 28,421 shares during the period. 77.09% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other Stryker news, CEO Kevin Lobo sold 57,313 shares of the company's stock in a transaction dated Thursday, November 7th. The shares were sold at an average price of $368.70, for a total transaction of $21,131,303.10. Following the transaction, the chief executive officer now directly owns 100,027 shares in the company, valued at approximately $36,879,954.90. This represents a 36.43 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 5.90% of the stock is owned by insiders.

Analysts Set New Price Targets

SYK has been the subject of several recent analyst reports. StockNews.com lowered shares of Stryker from a "buy" rating to a "hold" rating in a report on Thursday. UBS Group increased their target price on Stryker from $366.00 to $370.00 and gave the company a "neutral" rating in a research note on Wednesday, October 30th. Robert W. Baird increased their target price on Stryker from $378.00 to $405.00 and gave the stock an "outperform" rating in a research note on Wednesday, October 30th. Wells Fargo & Company raised their target price on shares of Stryker from $427.00 to $435.00 and gave the company an "overweight" rating in a research report on Wednesday. Finally, Canaccord Genuity Group lifted their price target on Stryker from $420.00 to $435.00 and gave the stock a "buy" rating in a report on Wednesday. Five equities research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Stryker presently has a consensus rating of "Moderate Buy" and an average price target of $416.40.

Stryker Trading Down 0.2 %

Shares of NYSE SYK traded down $0.59 during mid-day trading on Thursday, reaching $390.48. 1,681,743 shares of the company's stock were exchanged, compared to its average volume of 1,603,255. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.22 and a current ratio of 1.91. The firm has a market capitalization of $148.86 billion, a price-to-earnings ratio of 41.85, a PEG ratio of 2.68 and a beta of 0.95. The company's 50-day moving average is $376.55 and its 200-day moving average is $362.18. Stryker Co. has a 52-week low of $314.93 and a 52-week high of $406.19.

Stryker (NYSE:SYK - Get Free Report) last released its quarterly earnings data on Tuesday, January 28th. The medical technology company reported $4.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.87 by $0.14. Stryker had a return on equity of 23.07% and a net margin of 16.34%. During the same quarter in the previous year, the company posted $3.46 earnings per share. Analysts expect that Stryker Co. will post 12.06 EPS for the current fiscal year.

Stryker Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be paid a $0.84 dividend. This is a boost from Stryker's previous quarterly dividend of $0.80. This represents a $3.36 annualized dividend and a yield of 0.86%. The ex-dividend date of this dividend is Tuesday, December 31st. Stryker's payout ratio is currently 36.01%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.